**Some EU Countries Suspend Use of AstraZeneca Vaccine as Investigations Continue**
**Original Article Link:** https://news.google.com/read/CBMiVEFVX3lxTE5yMzRLeHJ3T2VLdTgyam5EQk1ocGVBa3luZElYbFdGUFU2VHZnRkNVUWgtYjlvTXhGRGFIUWg0MWtmcTFTVmtHQ1lKSmp1UHFTeWx1SA?hl=zh-CN&gl=CN&ceid=CN%3Azh-Hans
**Summary:**
Several European Union (EU) countries have temporarily suspended the use of the AstraZeneca COVID-19 vaccine as a precautionary measure while investigations into reports of blood clots in people who received the vaccine are ongoing. The European Medicines Agency (EMA) is currently reviewing the available data and has stated that there is no current evidence to suggest that the vaccine is the cause of the reported blood clots. However, the agency has recommended that countries suspend the use of the vaccine as a precaution until further information is available.
**Affected Countries:**
The following EU countries have suspended the use of the AstraZeneca vaccine:
* Austria
* Denmark
* Estonia
* Iceland
* Ireland
* Italy
* Latvia
* Lithuania
* Luxembourg
* Netherlands
* Norway
* Romania
* Spain
**Reported Cases:**
There have been a small number of reports of blood clots in people who received the AstraZeneca vaccine in the EU. The EMA is investigating these reports to determine whether there is a causal link between the vaccine and the blood clots. However, it is important to note that the number of reported cases is very small and that the overall risk of developing a blood clot after receiving the AstraZeneca vaccine is very low.
**EMA Statement:**
The EMA has stated that there is currently no evidence to suggest that the AstraZeneca vaccine is the cause of the reported blood clots. However, the agency has recommended that countries suspend the use of the vaccine as a precaution until further information is available. The EMA is expected to release an update on its investigation in the coming days.
**Next Steps:**
The EMA is continuing to investigate the reported cases of blood clots in people who received the AstraZeneca vaccine. The agency will release an update on its investigation in the coming days. In the meantime, the affected EU countries have suspended the use of the vaccine as a precautionary measure.
**Additional Information:**
The AstraZeneca COVID-19 vaccine is one of several vaccines that have been approved for use in the EU. The vaccine is effective in preventing COVID-19 and has been shown to be safe in clinical trials. However, as with any vaccine, there is a small risk of side effects. The most common side effects of the AstraZeneca vaccine include pain at the injection site, fatigue, headache, and muscle pain. These side effects are usually mild and go away within a few days.
If you have any questions or concerns about the AstraZeneca vaccine, please speak to your healthcare provider..
